Actively Recruiting
Predictive Value of Modified Caprini Score and D-Dimer in Managing Lower Limb Venous Thrombosis in Cardiothoracic Patients
Led by Al-Nahrain University · Updated on 2025-03-18
112
Participants Needed
1
Research Sites
27 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to evaluate the predictive efficacy of the Modified Caprini Risk Assessment Score and D-Dimer in identifying and managing lower extremity venous thrombosis (LEVT) among cardiothoracic surgery patients in Baghdad. The main questions it aims to answer are: Does combining the Modified Caprini Score with D-Dimer improve the accuracy of predicting lower extremity venous thrombosis (LEVT) compared to using each tool independently? Can these tools effectively guide clinical decisions for lower extremity venous thrombosis (LEVT) prevention and management in this patient population? Participants will: Undergo risk assessment for lower extremity venous thrombosis (LEVT) using the Modified Caprini Score and have their D-Dimer levels measured during their hospital stay. Be monitored for clinical outcomes, including confirmed lower extremity venous thrombosis (LEVT) incidence, need for anticoagulation therapy, and complications such as pulmonary embolism or recurrent thrombosis.
CONDITIONS
Official Title
Predictive Value of Modified Caprini Score and D-Dimer in Managing Lower Limb Venous Thrombosis in Cardiothoracic Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Inpatients with a hospital stay over 3 days
- Written informed consent obtained from patients or their legal guardians.
- Availability for postoperative follow-up to assess outcomes like LEVT development or related complications.
You will not qualify if you...
- Preexisting LEVT or Pulmonary Embolism diagnosed before the surgery.
- Severe bleeding disorders such as hemophilia or advanced liver disease.
- Currently receiving any anticoagulation therapy.
- Lack of postoperative D-dimer test results.
- Missing key clinical or laboratory data needed for score calculations.
- Pregnant women or those within six weeks postpartum.
- Unwilling or unable to follow study procedures and follow-up.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
College of Medicine - Al-Nahrain University
Baghdad, Iraq
Actively Recruiting
Research Team
A
Abdul-Ilah R. Khamis
CONTACT
L
Luma K Mohammed, MBChB,FIBMS/CM
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here